Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720Maria R. Baer, Richard A. Larson, Stephen L. George et al.|Blood|2002Cited by 366
Vitamin E. An inhibitor of the platelet release reaction.Marie E. Steiner, John Anastasi|Journal of Clinical Investigation|1976Cited by 209
Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720Maria R. Baer, Richard A. Larson, Stephen L. George et al.|Journal of Clinical Oncology|2008Cited by 131
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group studyHeesun J. Rogers, Eric D. Hsi, Y.-C. Liu et al.|Haematologica|2014Cited by 85